The Department brings together a globally-recognised scientists, academic clinicians and research facilitators to develop innovative technologies and translate them into clinical practice.
Our portfolio of platform technologies spans manufacture of biomaterials, biological applications of nanotechnology and tissue engineering, with applications to the clinic enabled by evidence based healthcare and clinical trials. Our aim is to drive uptake of innovative treatments and improve surgical practice to enhance patient benefit.
The Department is located at the Royal Free London NHS Trust in Hampstead, North London and embedded within clinical centres of excellence on the site. The vibrant mixture of UCL and NHS staff fosters close research links, based on strong scientific expertise aligned to clinical strengths. The emphasis is on translational outcomes.
We have international expertise in Biomaterials, Tissue Engineering for Regeneration, Transplantation Sciences, Vascular and Reconstructive Surgery, Nanomedicine and Solid Cancer Theranostics.
The Centres within the Department describe bench-to-clinic pathways based on our three major research streams.
We also have a diverse teaching portfolio of undergraduate and graduate programmes, which is based on and integrated with our research strengths.